This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MacKenzie, W. M. Articles by Blay, J. Search for Related Content PubMed PubMed Citation Articles by MacKenzie, W. M. Articles by Blay, J.

Adenosine Inhibits the Adhesion of Anti-CD3-activated Killer Lymphocytes to Adenocarcinoma Cells through an A₃ Receptor¹

Departments of Pharmacology [W. M. M., J. B.] and Microbiology and Immunology [D. W. H.], Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia B3H 4H7, Canada

We have investigated the hypothesis that adenosine, a purine nucleoside produced within hypoxic regions of solid tumors, may interfere with the recognition of tumor cells by cytolytic effector cells of the immune system. We measured the adhesion of murine spleen-derived anti-CD3-activated killer (AK) lymphocytes to syngeneic MCA-38 colon adenocarcinoma cells in a model system. Adenosine, in the presence of the adenosine deaminase inhibitor coformycin to prevent the breakdown of adenosine, inhibited adhesion by up to 60%. The inhibitory effect of adenosine was exerted on the AK cells and not on the MCA-38 targets. The response to adenosine was generated at the cell surface, since the inhibition of adhesion was not abrogated by S-(4-nitrobenzyl)-6-thioinosine or dipyridamole, which block adenosine uptake. The inhibition of adhesion due to adenosine was not blocked by either the A₁ receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine or the A₂ receptor antagonist 3,7-dimethyl-1-propargylxanthine. This suggested that a non-A₁, A₂ receptor might be involved. The relative order of potencies of adenosine and common analogues was: 5'-N-ethylcarboxamidoadenosine = adenosine = (R)-phenylisopropyladenosine > N⁶-cyclopentyladenosine > 2-chloro-N⁶-cyclopentyladenosine = 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethyl-carboxamidoadenosine. This agonist potency profile was again inconsistent with either the A₁ or the A₂ receptor subtype but indicated that the recently described A₃ receptor subtype might be responsible for the inhibition of adhesion. Consistent with this suggestion, aminophenylethyladenosine, an adenosine analogue that binds with high affinity to A₃ receptors, inhibited the adhesion of AK cells to MCA-38 tumor cells with high potency (50% inhibitory concentration 1 nM).

Adenosine, therefore, interferes with the AK cell recognition of colorectal tumor targets by acting through an A₃ receptor on the effector cells. We suggest that this mechanism of immunosuppression, secondary to tissue hypoxia, may be important in the resistance of colorectal and other solid cancers to immunotherapy.

¹ This research was supported by grants from the Dalhousie Faculty of Medicine Interdisciplinary Fund for Cancer Research (to J. B. and D. W. H.) and by support from the National Cancer Institute of Canada (to J. B.). W. M. M. is the recipient of a studentship from Ciba-Geigy/MRC of Canada.

² To whom requests for reprints should be addressed, at Department of Pharmacology, Dalhousie University, Rm. 5D-1B, Tupper Building, Halifax, Nova Scotia B3H 4H7, Canada.

Received 1/24/94. Accepted 5/ 4/94.

This article has been cited by other articles:

				E. Y. Tan, C. L. Richard, H. Zhang, D. W. Hoskin, and J. Blay Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway Am J Physiol Cell Physiol, September 1, 2006; 291(3): C433 - C444. [Abstract] [Full Text] [PDF]

				A. A. Erdmann, Z.-G. Gao, U. Jung, J. Foley, T. Borenstein, K. A. Jacobson, and D. H. Fowler Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo Blood, June 15, 2005; 105(12): 4707 - 4714. [Abstract] [Full Text] [PDF]

				S. Gessi, E. Cattabriga, A. Avitabile, R. Gafa', G. Lanza, L. Cavazzini, N. Bianchi, R. Gambari, C. Feo, A. Liboni, et al. Elevated Expression of A3 Adenosine Receptors in Human Colorectal Cancer Is Reflected in Peripheral Blood Cells Clin. Cancer Res., September 1, 2004; 10(17): 5895 - 5901. [Abstract] [Full Text] [PDF]

				H. Zhang, D. M. Conrad, J. J. Butler, C. Zhao, J. Blay, and D. W. Hoskin Adenosine Acts through A2 Receptors to Inhibit IL-2-Induced Tyrosine Phosphorylation of STAT5 in T Lymphocytes: Role of Cyclic Adenosine 3',5'-Monophosphate and Phosphatases J. Immunol., July 15, 2004; 173(2): 932 - 944. [Abstract] [Full Text] [PDF]

				E. Y. Tan, M. Mujoomdar, and J. Blay Adenosine Down-Regulates the Surface Expression of Dipeptidyl Peptidase IV on HT-29 Human Colorectal Carcinoma Cells: Implications for Cancer Cell Behavior Am. J. Pathol., July 1, 2004; 165(1): 319 - 330. [Abstract] [Full Text] [PDF]

				S. Gessi, K. Varani, S. Merighi, E. Cattabriga, A. Avitabile, R. Gavioli, C. Fortini, E. Leung, S. M. Lennan, and P. A. Borea Expression of A3 Adenosine Receptors in Human Lymphocytes: Up-Regulation in T Cell Activation Mol. Pharmacol., March 1, 2004; 65(3): 711 - 719. [Abstract] [Full Text] [PDF]

				K. Varani, R. Manfredini, V. Iannotta, C. Pancaldi, E. Cattabriga, C. Uluoglu, P. A. Borea, and F. Portaluppi Effects of Doxazosin and Propranolol on A2A Adenosine Receptors in Essential Hypertension Hypertension, December 1, 2002; 40(6): 909 - 913. [Abstract] [Full Text] [PDF]

				Z.-G. Gao, J. E. Van Muijlwijk-Koezen, A. Chen, C. E. Muller, A. P. Ijzerman, and K. A. Jacobson Allosteric Modulation of A3 Adenosine Receptors by a Series of 3-(2-Pyridinyl)isoquinoline Derivatives Mol. Pharmacol., November 1, 2001; 60(5): 1057 - 1063. [Abstract] [Full Text]

				C. P. Barry and S. E. Lind Adenosine-mediated Killing of Cultured Epithelial Cancer Cells Cancer Res., April 1, 2000; 60(7): 1887 - 1894. [Abstract] [Full Text]

				J. Spychala, A. G. Zimmermann, and B. S. Mitchell Tissue-specific Regulation of the Ecto-5'-nucleotidase Promoter. ROLE OF THE cAMP RESPONSE ELEMENT SITE IN MEDIATING REPRESSION BY THE UPSTREAM REGULATORY REGION J. Biol. Chem., August 6, 1999; 274(32): 22705 - 22712. [Abstract] [Full Text] [PDF]